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Abstract 
Background: To improve care and control for patients with adult-onset asthma, a better understanding of determi-
nants of their risk and outcomes is important. We investigated how associations between asthma, asthma control and 
obesity may be modified by patient demographic characteristics.
Methods: This retrospective study of adults enrolled in several health plans across the U.S. (n = 2,860,305) examined 
the interacting effects of obesity, age, race, and sex on adult-onset asthma and asthma control. Multivariable adjusted 
Cox and logistic regression models estimated hazard ratios (HR), and 95 % confidence intervals (CI) for the associa-
tions between body mass index (BMI) and study outcomes, and interactions of BMI with demographic characteristics.
Results: Compared with individuals who had a BMI <25 kg/m2, the hazard of adult-onset asthma progressively 
increased with increasing BMI, from a 12 % increase among persons with a BMI of 25.0–29.9 kg/m2 (HR 1.12, 95 % CI 
1.10, 1.14) to an almost 250 % increase among persons with a BMI ≥50 kg/m2 (HR 2.49, 95 % CI 2.38, 2.60). The mag-
nitude of the association between obesity and asthma risk was greater for women (compared with men) and lower 
for Blacks (compared with non-Hispanic Whites). Among individuals with asthma, obesity was associated with poorly 
controlled and high-risk asthma.
Conclusions: The present study demonstrates that the magnitude of the associations between obesity and adult-
onset asthma incidence and control are modified by race, age, and sex. Understanding the role of obesity in the 
development of adult-onset asthma will help to improve asthma treatment algorithms and to develop targeted 
interventions.
Keywords: Asthma, Adult-onset, Obesity, Race, Sex, Ethnicity
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Asthma is a chronic inflammatory disorder of the airways 
that involves a complex interaction of airflow obstruction, 
bronchial hyperresponsiveness, and underlying inflam-
mation [1]. The prevalence of asthma in the United States 
is about 9 % in women and 7 % in men [2]. While asthma 
often starts in early childhood, adult-onset asthma is 
often associated with poor control, more symptoms, and 
higher medication needs than pediatric-onset asthma [3]. 
To improve care and control for patients with adult-onset 
asthma, a better understanding of determinants of their 
risk and outcomes is important.
While several previous studies have shown that obesity 
is a risk factor for asthma [4], recent studies also indicate 
that patients with asthma who are obese may represent 
a clinically distinct subset of patients [5]. Compared 
to patients with asthma who are normal or overweight, 
patients with asthma who are obese have more severe 
and frequent respiratory symptoms, greater exacerba-
tion rates and reduced asthma-related quality of life [6]. 
Because most studies have not distinguished between 
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pediatric and adult-onset asthma, little is known about 
the risk and outcomes of adult-onset asthma, the role 
of obesity in asthma development, and how the risk of 
asthma among the individuals who are obese may be 
modified by other factors such as race/ethnicity and sex. 
Understanding the role of obesity in developing adult-
onset asthma and achieving control across heterogeneous 
groups of patients will help to improve asthma control 
algorithms and to develop targeted interventions. This 
knowledge will foster future patient-centered outcome 
studies to better understand patient barriers to asthma 
control among patients with asthma who are affected by 
obesity.
In this large, population-based cohort study using elec-
tronic health record (EHR) data of 2.8 million individuals 
who were members of nine different health plans across 
the United States, we examined the association between 
body weight and the incidence of adult-onset asthma. 
Among adults with incident adult-onset asthma, second-
ary outcomes such as poorly controlled asthma with or 
without high asthma medication ratio (AMR) as indica-
tor for difficulties to achieve asthma control, and high-
risk asthma, were examined. In addition, we examined 
race and sex as potential modifiers of the effect of body 
weight on asthma risk and outcomes.
Patients and methods
Study setting
This study was conducted by the patient outcomes 
research to advance learning (PORTAL) network. The 
health care systems in the PORTAL network collectively 
include 11 million members, as previously described [7, 
8]. In brief, PORTAL includes Kaiser Permanente, Group 
Health Cooperative, HealthPartners, and Denver Health. 
The cohort is racially and socioeconomically diverse, 
and generally representative of the underlying popula-
tions of the health plans’ service regions [9, 10]. All POR-
TAL sites contributed data for the present study except 
HealthPartners.
The study protocol was reviewed and approved by the 
Institutional Review Board (IRB) of Kaiser Permanente 
Southern California (KPSC) as the lead site. The IRBs at 
the other sites reviewed the protocol and subsequently 
ceded review to the KPSC IRB.
Study design and population
We performed a retrospective cohort study using the 
PORTAL overweight/obesity cohort, which includes over 
5 million adults with a BMI ≥23.0 kg/m2 in 2012–2013. A 
detailed description of the cohort is provided elsewhere 
[8]. Briefly, the PORTAL overweight/obesity cohort con-
sisted of individuals who were 18  years of age and older 
when entering the cohort, had 1 year of continuous mem-
bership in any of the contributing health plans prior to 
entering the cohort and had at least one outpatient med-
ically-related visit with a biologically plausible recorded 
measure of weight and height with a BMI of ≥23.0 kg/m2 
at any time between 2012 and 2013 (n = 5,293,458).
The study has a mixed longitudinal (primary study out-
come) and cross-sectional (secondary study outcomes) 
design (Fig.  1). A cohort baseline date was assumed on 
January 1, 2011. To exclude the possibility of preexist-
ing asthma based on at least 2 years of medical history, 
we restricted the original PORTAL cohort to individu-
als who were also enrolled in one of the health plans in 
2009 and 2010 (n  =  4,568,725). We excluded patients 
who were not at least 18 years of age at cohort baseline 
(n = 331,504) or who did not have a measure of weight, 
height, or BMI in the EHR within a year prior to the 
cohort baseline (n  =  817,674). We then excluded indi-
viduals with a history of asthma and other chronic pul-
monary diseases (Table 1; n = 559,242). The final analytic 
cohort consisted of 2,860,305 individuals.
Weight and height
We used weight and height measurements extracted 
from outpatient clinic visits before but closest to the 
index date (at maximum 1 year prior to the index date) 
to calculate baseline BMI [8]. Weight is routinely meas-
ured as part of obtaining vital signs during outpatient 
clinic visits at PORTAL sites. Height is typically assessed 
less often, as it is considered to be more static. BMI is 
calculated within the EHR. A height <4 ft or ≥8 ft or a 
weight  <50  lbs or  ≥1000  lbs were considered implau-
sible and removed from the data. Similarly, a calculated 
BMI  <5  kg/m2 or  ≥90  kg/m2 was excluded. A total of 
6954 (0.1  %) individuals were excluded from the cohort 
because they had no biologically plausible weight, height, 
or BMI values.
We categorized individuals based on their baseline 
BMI as normal weight (BMI  <25  kg/m2), overweight 
(25.0–29.9 kg/m2), obese class 1 (30.0–34.9 kg/m2), obese 
class 2 (35.0–39.9  kg/m2), obese class 3 (40.0–49.9  kg/
m2), and obese class 4 (≥50  kg/m2) [11, 12]. We classi-
fied Asians in the same manner for the main analysis. 
Because the baseline BMI used for this study was in 2011 
not 2012/2013 as for the PORTAL overweight/obesity 
cohort, the normal weight category includes of individu-
als with a BMI  <23  kg/m2 before 2012/2013. For a sec-
ondary analysis, we classified Asians as normal weight 
(BMI  <23  kg/m2), overweight (23.0–24.9  kg/m2), obese 
class 1 (25.0–29.9  kg/m2), obese class 2 (30.0–34.9  kg/
m2), obese class 3 (35.0–39.9  kg/m2), and obese class 4 
(≥40 kg/m2) [13].
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Race and ethnicity
Based on the self-reported identification from admin-
istrative records, individuals were categorized as Asian, 
Black or African American, Hispanic, Native Hawaiian or 
other Pacific Islander, American Indian/Alaskan Native 
(AIAN), non-Hispanic White, or other/unknown [14]. 
Hispanic ethnicity took priority over any racial category.
Socioeconomic status
As indicator of socioeconomic status, two measures were 
used: neighborhood education and insurance through 
government health care assistance programs.
Neighborhood education was estimated using geospa-
tial entity object codes (geocodes) that linked addresses to 
2010 United States census data at the block group level. The 
probability of high school graduation or less within a block 
group was used and low neighborhood education defined 
as the probability of a high school education or less above 
the population median. Individuals with missing neighbor-
hood education (n = 82,833) were assigned the mean prob-
ability of high school graduation for their region.
Information on insurance through government health care 
assistance programs for individuals with low income and 
limited resources such as Medicaid (yes/no) was extracted 
from insurance plan administrative information. Individuals 
with missing insurance information (n = 853) were assigned 
to no government health care assistance programs.
Oral contraceptive use
Because female sex hormones are a risk factor for asthma 
[3] and are associated with obesity, woman were identi-
fied as using oral contraceptives if oral contraceptives 
were dispensed at least once at any point between 2009 
and the end of follow-up for the primary study outcome.
Definition of study outcomes
The primary study outcome was adult-onset asthma 
defined as (1) one or more hospitalization or emergency 
department visit with any diagnosis of asthma [Interna-
tional Classification of Disease (ICD), 9th modification 
ICD-9 diagnosis code 493.x], (2) two or more ambulatory 
visits with diagnosis of asthma, or (3) at least one visit 
with a diagnosis of asthma in combination with at least 
one dispensing of asthma-related medication in the year 
following the diagnosis [15, 16]. The outcome date was 
defined as the first date for which a patient met 1 of the 
above criteria.
The secondary study outcomes were poorly controlled 
asthma with or without high AMR as indicator for dif-
ficulties to achieve asthma control and high-risk asthma. 
For these secondary study outcomes, the cohort was 
limited to individuals with adult-onset asthma, at least 
12  months of follow-up after the first diagnosis, and 
medication dispense information available (n = 140,403).
The secondary outcomes were defined based on asthma 
medications and asthma-related utilization as follows:
Asthma medication dispenses were extracted from 
the EHR. Medications classified as controllers included 
inhaled corticosteroids (flunisolide, mometasone, tri-
amcinolone, ciclesonide, fluticasone, budesonide, 
beclomethasone), combined inhaled corticosteroids/
long-acting β-agonists (fluticasone/salmeterol, mometa-
sone/formoterol, budesonide/formoterol), methylxan-
thines (aminophylline, dyphylline, theophylline), mast 
cell stabilizer (cromolyn), and leukotriene receptor 
antagonists (montelukast, zafirlukast, zileuton) [17]. 
Medications classified as controllers did not include oral 
corticosteroids. Reliever (rescue) medications included 
inhaled short-acting β-agonists (albuterol, levalbuterol, 
metaproterenol) [17]. For persons with asthma and at 
least 1 year of follow-up, the number and type of medi-
cations dispensed during the 1-year period following the 
incidence date of asthma diagnosis were examined for 
characterization of asthma severity and control.
An asthma medication ratio was calculated according 
to the specifications of the National Committee for qual-
ity assurance [17]. The asthma medication ratio (AMR) 
is defined as the number of controller medication fills 
divided by the sum of the number of controller and res-
cue medication fills. Both medications were weighted for 
the number of doses per container to account for differ-
ences between products [17, 18]. The AMR generally is 
calculated over a 1-year period and ranges from 0 to 1 
where 1 is ideal (i.e., all controller and no rescue medi-
cations). We categorized the AMR as “high” (>=0.5) or 
“low” (<0.5), which previously has been shown to be 
associated with patient outcomes [16, 19, 20].
The amount of dispensing of rescue medication over 
1  year is an indicator of long-term asthma control [16, 
20]. Asthma control was defined based on the num-
ber of rescue medication canisters dispensed in the first 
Table 1 Exclusion and censoring criteria
Medical condition International classification 
of disease, 9th modification 
ICD-9 diagnosis code
Emphysema 492.x
Chronic obstructive pulmonary dis-
ease including chronic bronchitis
490.x–491.x
Bronchiectasis 494.x
Chronic airway obstruction 496.x
Chronic respiratory conditions due 
to fumes and vapors
506.4
Cystic fibrosis 277.0
Prior history of asthma 493.x
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12  months after diagnosis and categorized as “poorly 
controlled” (>=6 canisters) or “adequately controlled” 
(<6 canisters) [18]. Poorly controlled asthma can be 
related to factors such as higher asthma severity, inade-
quate controller prescribing, poor medication adherence, 
environmental exposures or unaddressed comorbidities 
[21].
To distinguish between poorly controlled with low or 
high AMR as indicator for difficulties to achieve asthma 
control, we divided patients with poorly controlled 
asthma into those with low (<0.5) and high AMR (>=0.5) 
[18, 19].
High-risk asthma was defined as having 1 or more 
asthma-related emergency department visits and/or 1 or 
more oral steroid dispensing within 7 days of an asthma-
related ambulatory visit during the 1-year follow up [18].
Cohort follow-up
For the primary study outcome, adult-onset asthma, indi-
viduals were passively followed through June 30, 2014 
using information from the EHR. The follow-up time was 
calculated from January 1, 2011 until the first occurrence 
of one of the following events: diagnosis of adult-onset 
asthma, diagnosis of other chronic pulmonary diseases, 
the end of health care coverage, death, or the end of fol-
low-up on December 31, 2014.
Statistical analysis
Demographic and clinical characteristics were summa-
rized as absolute numbers and proportions and reported 
by weight status. Chi squared tests were used to assess 
differences in proportions of demographic and clinical 
characteristics. These characteristics were examined and 
compared for each site to ensure there were no system-
atic site-level differences.
The association between baseline weight status and 
asthma risk was evaluated using hazard ratios (HR) esti-
mated from Cox proportional hazard models with per-
son-time of follow-up as the time scale adjusted for or 
stratified by age, sex, race/ethnicity, insurance through 
government health care assistance programs, neighbor-
hood education level, oral contraceptive use, and site. We 
examined the association of BMI and asthma risk within 
strata of potential effect modifiers. Tests of linear trends 
across weight category were conducted by considering 
weight category as a continuous variable in the multi-
variate model. To investigate whether the association 
between asthma risk and BMI category was modified 
by other potential risk factors for asthma, we performed 
tests for multiplicative interaction using likelihood-ratio 
tests. All HRs are displayed with 95 % confidence inter-
vals (CI); reported P values for trends and interactions 
are based on 2-sided tests.
Among adults with adult-onset asthma and at least 
12  months of follow-up (Fig.  1), associations among 
weight status and asthma-specific outcomes were 
assessed. We also examined how associations were 
modified by sex, race, and other factors. Due to smaller 
cell sizes, Asian, Pacific Islander, and AIAN races were 
combined into one category for these secondary analy-
ses. Odds ratios (OR) for the association between weight 
status and poorly controlled asthma with low or high 
AMR, and high-risk asthma were estimated using logistic 
regression adjusted for age, sex, race/ethnicity, insurance, 
neighborhood education level, oral contraceptive use and 
site. Sensitivity analyses were performed excluding per-
sons with missing neighborhood education (n = 82,833) 
and insurance (n =  853) information as well as remov-
ing education and insurance as covariates with essentially 
unaltered results. All statistical analyses were conducted 
using SAS version 9.3 (SAS Institute, Inc., Cary, NC, 
USA).
Results
The PORTAL cohort is ethnically and racially diverse 
with 49.4  % non-Hispanic Whites, 23.0  % Hispanics, 
11.4 % Blacks and 10.5 % Asians (Table 2). With increas-
ing weight class, individuals were more likely to be in 
the age group between 40–60 years of age, female, non-
White, a recipient of care through a government insur-
ance program for individuals with low income and 
limited resources such as Medicaid, and a resident of a 
neighborhood with higher educational attainment.
During 11,753,217 person-years of follow-up (median 
follow-up time 4.5 years), we identified 140,403 individu-
als who met the study definition of adult-onset asthma. 
In multivariate-adjusted models, a new diagnosis of 
asthma was more common among women, younger indi-
viduals, members of selected racial groups, and persons 
with lower socioeconomic status (SES) (Fig. 2).
The risk for adult-onset asthma was strongly and posi-
tively associated with BMI categories. In multivariate-
adjusted models, the hazard of developing adult-onset 
asthma progressively increased with higher BMI cat-
egories, from a 12  % increase among persons with a 
BMI of 25.0–29.9  kg/m2 (HR 1.12, 95  % CI 1.10, 1.14) 
to an almost 250  % increase among persons with a 
BMI ≥50 kg/m2 (HR 2.49, 95 % CI 2.38, 2.60) (Table 3).
To evaluate whether the association between BMI and 
adult-onset asthma was modified by age, sex and race, we 
tested for interaction effects and repeated our analyses 
within subgroups defined by those variables (Table  3). 
The association of BMI to asthma incidence appeared to 
be stronger among women than among men, and in older 
(40–65 and 65+ year) compared with younger individu-
als (18–39 year; P value for interaction <0.001).
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The association of BMI and asthma incidence also 
appeared to be stronger among Asians and weaker among 
Blacks than among other races/ethnicities (P value for 
interaction < 0.001, Fig. 3). When applying Asian-specific 
BMI thresholds to compare the risk for asthma across 
the different weight classes, the association of obesity to 
asthma was comparable between Asians and non-His-
panic Whites (Fig. 3).
For women, the association of BMI to adult-onset 
asthma was stronger among oral contraceptives non-
users than among users (P value for interaction < 0.001). 
For example, the HR was 2.97 (95  % CI 2.80, 3.15) for 
non-users and 2.06 (95  % CI 1.89, 2.24) for users with 
a BMI  ≥50  kg/m2 when compared with their normal 
weight counterparts (Table 3).
The association of body weight to adult-onset asthma 
in all subgroups defined by age and race was roughly 
comparable among men and women after further strati-
fying by sex (Table 3).
In individuals with adult-onset asthma and at least 1 year 
of follow up, we examined the association of body weight 
class and asthma outcomes. Poorly controlled asthma 
(3083 cases) including poorly controlled asthma with high 
AMR (758 cases), and high-risk asthma (17,204 cases) 
were more prevalent at higher BMI categories (Table  4). 
The OR for poorly controlled asthma for individuals with a 
BMI <25 kg/m2, 25.0–29.9 kg/m2, 30.0–34.9 kg/m2, 40.0–
49.9  kg/m2, and  ≥50  kg/m2 were 1.00, 0.97, 1.03, 1.13, 
1.13 and 1.46 (95  % CI 1.13, 1.88), respectively. The OR 
for poorly controlled asthma with high AMR for individu-
als with a BMI <25 kg/m2, 25.0–29.9 kg/m2, 30.0–34.9 kg/
m2, 40.0–49.9 kg/m2, and ≥50 kg/m2 were 1.00, 1.12, 1.21, 
1.26, 1.25 and 2.08 (95 % CI 1.31, 3.31), respectively. The 
OR for high-risk asthma were 1.00, 1.03, 1.17, 1.30, 1.37, 
and 1.63 (95 % CI 1.45, 1.84), respectively.
The magnitude of the association between BMI and 
poorly controlled asthma (P value for interaction < 0.001) 
and high-risk asthma (P value for interaction < 0.001) was 
Table 2 Distribution of baseline demographic characteristics of PORTAL patients (n = 2,860,305)
Chi squared tests were used to assess differences in proportions of demographic and clinical characteristics across different weight classes. P < 0.001 for all 
demographic and clinical characteristics shown
AIAN American Indian/American Native; BMI body mass index
Total population BMI (kg/m2)
<25 25.0–29.9 30.0–34.9 35.0–39.9 40.0–49.9 ≥50
N (%)
 Age (years)
  18–39 700,548 (24.5 %) 187,257 (31.2 %) 260,014 (22.5 %) 141,290 (21.5 %) 64,996 (23.7 %) 39,778 (26.6 %) 7213 (30.1 %)
  40–65 1,507,052 (52.7 %) 269,106 (44.9 %) 605,983 (52.4 %) 369,320 (56.3 %) 159,459 (58.1 %) 88,592 (59.3 %) 14,592 (60.9 %)
  65+ 652,705 (22.8 %) 143,604 (23.9 %) 290,840 (25.1 %) 145,162 (22.1 %) 50,046 (18.2 %) 20,906 (14.0 %) 2147 (9.0 %)
 Sex
  Male 1,307,645 (45.7 %) 223,739 (37.3 %) 587,681 (50.8 %) 323,679 (49.4 %) 114,094 (41.6 %) 50,906 (34.1 %) 7546 (31.5 %)
  Female 1,552,660 (54.3 %) 376,228 (62.7 %) 569,156 (49.2 %) 332,093 (50.6 %) 160,407 (58.4 %) 98,370 (65.9 %) 16,406 (68.5 %)
 Race/ethnicity
  Non-Hispanic 
White
1,413,998 (49.4 %) 305,329 (50.9 %) 575,541 (49.8 %) 318,138 (48.5 %) 132,652 (48.3 %) 71,183 (47.7 %) 11,155 (46.6 %)
  Hispanic 656,642 (23.0 %) 105,589 (17.6 %) 263,032 (22.7 %) 173,604 (26.5 %) 72,069 (26.3 %) 36,972 (24.8 %) 5376 (22.4 %)
  Black 327,148 (11.4 %) 46,157 (7.7 %) 113,792 (9.8 %) 87,652 (13.4 %) 44,754 (16.3 %) 29,181 (19.5 %) 5612 (23.4 %)
  Asian 301,722 (10.5 %) 108,670 (18.1 %) 138,957 (12.0 %) 40,504 (6.2 %) 9845 (3.6 %) 3422 (2.3 %) 324 (1.4 %)
  Pacific Islander 37,719 (1.3 %) 7335 (1.2 %) 13,976 (1.2 %) 8660 (1.3 %) 4321 (1.6 %) 2821 (1.9 %) 606 (2.5 %)
  AIAN 14,552 (0.5 %) 2493 (0.4 %) 5189 (0.4 %) 3675 (0.6 %) 1850 (0.7 %) 1115 (0.7 %) 230 (1.0 %)
  Other/unknown 108,524 (3.8 %) 24,394 (4.0 %) 46,350 (4.0 %) 23,539 (3.6 %) 9010 (3.3 %) 4582 (3.1 %) 649 (2.7 %)
 Health care assistance
  No 2,809,762 (98.2 %) 590,175 (98.4 %) 1,139,813 (98.5 %) 643,938 (98.2 %) 268,196 (97.7 %) 144,760 (97.0 %) 22,880 (95.5 %)
  Yes 50,543 (1.8 %) 9792 (1.6 %) 17,024 (1.5 %) 11,834 (1.8 %) 6305 (2.3 %) 4516 (3.0 %) 1072 (4.5 %)
 Neighborhood education
  Low 1,387,326 (48.5 %) 328,707 (54.8 %) 582,814 (50.4 %) 295,934 (45.1 %) 114,239 (41.6 %) 57,322 (38.4 %) 8310 (34.7 %)
  High 1,472,979 (51.5 %) 271,260 (45.2 %) 574,023 (49.6 %) 359,838 (54.9 %) 160,262 (58.4 %) 91,954 (61.6 %) 15,642 (65.3 %)
 Oral contraceptives (women only)
  Yes 467,551 (16.3 %) 133,053 (22.2 %) 168,619 (14.6 %) 91,033 (13.9 %) 43,140 (15.7 %) 26,925 (18.0 %) 4781 (20.0 %)
  No 2,392,754 (83.7 %) 466,914 (77.8 %) 988,218 (85.4 %) 564,739 (86.1 %) 231,361 (84.3 %) 122,351 (82.0 %) 19,171 (80.0 %)
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stronger among younger compared with older individuals, 
while the magnitude of the association between BMI and 
poorly controlled asthma with high AMR was compara-
ble across all age groups (P value for interaction = 0.075). 
The magnitude of the association between BMI and 
high-risk asthma (P value for interaction  <  0.001) was 
stronger among Asians, Pacific Islanders and AIAN than 
among other races, while the magnitude of the associa-
tion between BMI and poorly controlled asthma (P value 
for interaction =  0.055), especially for poorly controlled 
asthma with high AMR (P value for interaction = 0.357) 
was comparable across all racial/ethnic groups.
Discussion
Obesity has been previously recognized as a risk factor 
for adult-onset asthma. We demonstrated that excessive 
body weight was associated with a 40  % higher risk of 
asthma for individuals affected by obesity with a BMI of 
30.0–34.9  kg/m2 and almost 250  % higher risk for indi-
viduals with a BMI of over 50 kg/m2 compared to individ-
uals with a normal weight BMI <25 kg/m2. We also found 
that the magnitude of this association may be altered by 
age, sex, and race. Women, older adults, and individuals 
of Asian origin carried a higher obesity-related risk to 
develop asthma during adulthood than other population 
groups. Furthermore, among individuals with asthma, 
greater BMI was associated with higher odds for poorly 
controlled and high-risk asthma across all racial and eth-
nic groups. In addition, the obesity-related risk for poorly 
controlled and high-risk asthma increased with age, and 
was marginally to significantly higher among individuals 
of Asian origin.
Asthma is a heterogeneous disease with many pheno-
types, and age at disease onset is an important factor in 
Relative risk (95%-CI)




































































Fig. 2 Risk for asthma by age, sex, race and sociodemographic characteristics
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separating the phenotypes. Patients with childhood-onset 
asthma are typically atopic with a relatively good progno-
sis [22]. In contrast, patients with adult-onset asthma are 
most often non-atopic females without a family history of 
asthma or allergies, have a less favorable prognosis, and 
are more likely to develop persistent airflow limitation [3, 
23, 24]. Asthma in patients affected by obesity, especially 
in women, has been identified as a distinct phenotype 
characterized by frequent symptoms, frequent exacer-
bations and high health care utilization [24]. The results 
from our study contribute to the evidence that asthma is 
not only more likely to develop in individuals affected by 
obesity, but also that existing asthma is complicated by 
obesity, with some demographic subgroups experienc-
ing worse asthma control than others. With more than 
one-third of U. S. adults considered obese, clinical care 
approaches, asthma risk stratification algorithms and 
population management strategies may benefit from tak-
ing into account that obesity can alter asthma outcomes 
for some population groups.
Several cross-sectional and prospective studies, as 
well as systematic reviews and meta-analyses, provide 
compelling evidence that obesity increases the risk of 
asthma in children and adults [4, 25–27]. However, only 
a few studies were able to distinguish between child- and 
adult-onset of asthma and provide estimates for the mag-
nitude of the association of obesity class 2 and higher 
[4]. According to a meta-analysis based on prospective 
studies, the odds of developing asthma for individuals 
with obesity compared to those with normal weight were 
twice as high (OR 1.92, 95  % CI 1.43–2.59) [4]. Cross-
sectional data from the National Health and Nutrition 
Examination Survey (NHANES), 2001–2004, showed an 
OR of 1.80 (95 % CI 1.40–2.30) for a BMI of 30.0–34.9 kg/
m2, and 2.40 (95 % CI 1.60–3.70) for a BMI >40.0 kg/m2 
compared to their normal weight counterparts [28]. In 
the Black Women’s Health Study, the incidence rate ratios 
ranged from 1.26 (95  % CI 1.05–1.51) for women with 
overweight to 2.85 (95 % CI 2.19–3.72) for women with 
a BMI ≥40 kg/m2 when compared to women with a BMI 
of 20–24.9 kg/m2 [29]. Compared to other studies [4, 28, 
29], our HRs are slightly lower, but this can be partially 
explained by the higher BMI of our normal weight con-
trol group (23.0–24.9 as opposed to 19.0–24.9).
Several mechanisms for the contribution of obesity to 
asthma risk have been implicated [3, 30]. Obesity is asso-
ciated with increased levels of adipokines, which may 
affect the airway directly, rather than through increased 
airway inflammation [31]. Additionally, mechanical fac-
tors such as reduced functional residual capacity that can 
occur with more severe obesity may result in expiratory 
flow limitation and airway closure [32].
Sex has been previously shown to alter the associa-
tion between obesity and asthma. In a meta-analyses, the 
odds for asthma among women with overweight and obe-
sity were almost 70 % higher (OR 1.68, 95 % CI 1.45, 1.94) 
than that found for men with overweight and obesity 
(1.46, 95 % CI 1.05, 2.02) compared to their counterparts 
with normal weight [4]. Extending these findings, we 
observed an asthma risk increase between 43 and 260 % 
for women and between 26 and 220 % for men with obe-
sity class 1 to class 4 compared to their counterparts with 
normal weight. While both sexes in our study showed a 
strong risk increase with higher BMI, the association was 
significantly altered by sex, showing a higher obesity-
related burden for asthma in women. The obesity-related 
risk for asthma was also modified by age, showing an 
increased risk with higher age in both, men and women. 
A potential role of hormonal factors as explanation of sex 
differences is supported by the effect modification of oral 
contraceptive use among women. The obesity-related 
risk for asthma was more pronounced in women who did 
not use oral contraceptives (OR 2.97, 95 % CI 2.80, 3.15) 
than in those taking oral contraceptives (OR 2.06, 95  % 
CI 1.89, 2.24). Results from other studies indicated that 
oral contraceptive use lowered the risk for asthma in girls 
during puberty [33] and decreased the risk for asthma 
and asthma exacerbations in Scottish women [34].
One previous study investigated the effect modification 
of race/ethnicity on the association between BMI and risk 
of asthma [35]. Results from that study suggested that 
obesity is a strong risk factor for asthma among Blacks 
(OR for BMI ≥30 kg/m2 = 2.90, 95 % CI 1.20, 7.00) and 
Hispanic men (OR for BMI ≥30 kg/m2 = 2.70, 95 % CI 
1.10, 6.30) but not in non-Hispanic White men (OR for 
BMI ≥30 kg/m2 = 1.00, 95 % CI 0.60, 1.70) compared to 
their counterparts with normal weight of the same race/
ethnicity. However, the statistical power was limited due 
to a relatively small sample size for minority men [35]. 
These findings are not consistent with our results. We 
noted a comparable obesity–related burden across most 
races/ethnicities in men and women except for individu-
als of Asian origin and Blacks. While Asians appeared to 
have a slightly lower overall risk for asthma compared to 
Non-Hispanic Whites in the present study, they exhib-
ited a greater increase in asthma risk with increasing BMI 
than other races/ethnicities. However, when applying 
Asian-specific BMI thresholds to define overweight and 
obesity, the relation of obesity to asthma risk was com-
parable with most other races. In Blacks, the increase in 
asthma risk associated with higher BMI appeared to be 
smaller than in other races.
While asthma is a common comorbidity among per-
sons with obesity, our study suggests that obesity not 
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Fig. 3 Risk for asthma across the different weight class
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only increases the risk for asthma, but also adversely 
affects asthma severity and control. Increasing obesity 
was associated with less favorable asthma outcomes 
across all racial and ethnic groups. But similar to the 
risk of developing adult-onset asthma, the risk associ-
ated with obesity class 4 for poorly controlled and high 
risk asthma was greater in adults who were elderly, and 
was marginally to significantly greater among individuals 
of Asian origin when using standard BMI thresholds. In 
contrast, increasing obesity was associated with poorly 
controlled asthma with high AMR across all subgroups.
Several biological and non-biological mechanisms have 
been suggested to explain a relationship between obesity 
and poor asthma outcomes, including reduced corticos-
teroid responsiveness in obese individuals [36–38], the 
influence of immunomodulatory adipokines [39, 40], 
deleterious effects on pulmonary mechanics [39], low 
vitamin D levels [41, 42], and obesity-related comorbidi-
ties such as gastro-esophageal reflux disease (GERD) and 
depression [40, 43]. However, a recent study suggested 
that obesity was associated with poor asthma control 
even after adjusting for GERD, depression, and corticos-
teroid use [15]. No studies could be identified that inves-
tigated the modification of association between obesity 
and asthma outcomes by race and ethnicity, age, and sex.
We noted several potential limitations. Due to the 
inclusion criteria for the PORTAL obesity cohort, indi-
viduals were required to have a BMI of at least 23.0 kg/
m2 in 2012 or 2013. Thus, our study population may not 
reflect normal weight individuals ranging from 19.0–
22.9 kg/m2 who are included in most other studies. How-
ever, the difference in the range of normal weight will 
lead to an underestimation of the risk associated with 
high BMI. Furthermore, this is unlikely to affect the inter-
actions that were the focus of the present study. A unique 
strength of our study is that we examined the risk for 
asthma among individuals with severe obesity and exam-
ined relevant subgroups stratified by sex, age, and race. 
Although we were not able to account for changes in the 
BMI during follow-up, this is unlikely to influence the 
results, considering the relatively short follow-up and the 
time of exposure to obesity.
Our definition of adult-onset may have resulted in mis-
classification of recrudescent pediatric-onset asthma as 
adult-onset asthma, especially in younger adults. How-
ever, the misclassification is unlikely to be differential 
across weight classes and, therefore, should not affect the 
nature or the magnitude of the results presented here.
Several studies have suggested that asthma, especially 
adult-onset asthma, may be overdiagnosed in individu-
als affected by obesity [44, 45]. Individuals with asthma 
and obesity have a lower lung function and more comor-
bidities compared to individuals with asthma who are 
normal weight; if making urgent visits for respiratory 
symptoms, individuals affected by obesity are more likely 
to receive a misdiagnosis of asthma [46]. For the present 
study, a potential overdiagnosis of asthma in individuals 
affected by obesity when seeking urgent care would result 
in an overestimation of the association between obesity 
and asthma, especially the association between obesity 
and high-risk asthma. We can also not exclude that dif-
ferential utilization of health care service such as higher 
utilization among women or lower utilization among 
Hispanics or Blacks may have contributed to differential 
chance of diagnosis with asthma.
Moreover, the relatively short follow-up times may 
mask some effect modification that may be apparent over 
longer periods of time. Generally, a short follow-up is 
likely to bias results towards the null. Future studies with 
a longer follow-up period are required to identify those 
effect modifications.
A small proportion of the study population was clas-
sified as other or unknown race/ethnicity. Incomplete 
assessment of race/ethnicity is usually caused by shorter 
enrollment [14, 47] and unlikely to be differential across 
different weight classes and, therefore, unlikely to affect 
the results. In addition, risk estimates of individuals clas-
sified as other or unknown were roughly comparable to 
the largest represented racial groups, i.e., non-Hispanic 
Whites, Hispanic, and Blacks, and unlikely to mask a 
significant effect modification in a small racial subgroup 
with differential classification as other or unknown racial 
origin.
Conclusions
We found that the associations between obesity and 
asthma and asthma control were significantly altered 
by age, sex, and race. Among individuals with asthma, 
increasing obesity was associated with poorer asthma 
outcomes, which was more pronounced in adults who 
were older. Understanding the role of obesity in the 
development of adult-onset asthma will help to improve 
asthma treatment algorithms, design patient-centered 
outcome studies to better understand patient barriers to 
asthma control, and to develop targeted interventions.
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